JP2009149554A - Skin preparation for external use, having oil-in-water emulsion form - Google Patents
Skin preparation for external use, having oil-in-water emulsion form Download PDFInfo
- Publication number
- JP2009149554A JP2009149554A JP2007328303A JP2007328303A JP2009149554A JP 2009149554 A JP2009149554 A JP 2009149554A JP 2007328303 A JP2007328303 A JP 2007328303A JP 2007328303 A JP2007328303 A JP 2007328303A JP 2009149554 A JP2009149554 A JP 2009149554A
- Authority
- JP
- Japan
- Prior art keywords
- fatty acid
- oil
- external preparation
- skin
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 51
- 239000007764 o/w emulsion Substances 0.000 title abstract description 4
- -1 fatty acid ester Chemical class 0.000 claims abstract description 68
- 239000000194 fatty acid Substances 0.000 claims abstract description 54
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 48
- 229930195729 fatty acid Natural products 0.000 claims abstract description 48
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims abstract description 34
- 239000002537 cosmetic Substances 0.000 claims abstract description 24
- 238000006116 polymerization reaction Methods 0.000 claims abstract description 23
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 16
- 239000004094 surface-active agent Substances 0.000 claims abstract description 16
- 239000000344 soap Substances 0.000 claims abstract description 12
- 239000007788 liquid Substances 0.000 claims abstract description 11
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims abstract description 9
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims abstract description 9
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229920000642 polymer Polymers 0.000 claims abstract description 9
- 150000003839 salts Chemical class 0.000 claims abstract description 9
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 claims abstract description 8
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 claims abstract description 8
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims abstract description 7
- VBICKXHEKHSIBG-UHFFFAOYSA-N beta-monoglyceryl stearate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims abstract description 7
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical compound CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229960000541 cetyl alcohol Drugs 0.000 claims abstract description 4
- 229960000735 docosanol Drugs 0.000 claims abstract description 4
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 claims abstract description 4
- IWWCATWBROCMCW-UHFFFAOYSA-N batyl alcohol Natural products CCCCCCCCCCCCCCCCCCOC(O)CO IWWCATWBROCMCW-UHFFFAOYSA-N 0.000 claims abstract description 3
- 229940012831 stearyl alcohol Drugs 0.000 claims abstract description 3
- 239000003995 emulsifying agent Substances 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- 239000000843 powder Substances 0.000 abstract description 16
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 11
- 239000012071 phase Substances 0.000 description 11
- 239000002253 acid Substances 0.000 description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 229920001296 polysiloxane Polymers 0.000 description 8
- 239000006096 absorbing agent Substances 0.000 description 7
- 235000011187 glycerol Nutrition 0.000 description 7
- 229960005150 glycerol Drugs 0.000 description 7
- 239000002202 Polyethylene glycol Substances 0.000 description 6
- 239000004359 castor oil Substances 0.000 description 6
- 235000019438 castor oil Nutrition 0.000 description 6
- 150000002148 esters Chemical class 0.000 description 6
- 239000000499 gel Substances 0.000 description 6
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 6
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical group CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 229920001223 polyethylene glycol Polymers 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 5
- 238000004945 emulsification Methods 0.000 description 5
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 5
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 5
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical group CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 239000004166 Lanolin Substances 0.000 description 4
- 235000021355 Stearic acid Nutrition 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 230000002776 aggregation Effects 0.000 description 4
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical group CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 4
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid ester group Chemical group C(CCCCCCCCCCC)(=O)O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 235000019388 lanolin Nutrition 0.000 description 4
- 229940039717 lanolin Drugs 0.000 description 4
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N palmitic acid group Chemical group C(CCCCCCCCCCCCCCC)(=O)O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- 229960004274 stearic acid Drugs 0.000 description 4
- 239000008117 stearic acid Substances 0.000 description 4
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 3
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 229960003237 betaine Drugs 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid group Chemical group C(CCCCCCC\C=C/CCCCCCCC)(=O)O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- ZONJATNKKGGVSU-UHFFFAOYSA-N 14-methylpentadecanoic acid Chemical group CC(C)CCCCCCCCCCCCC(O)=O ZONJATNKKGGVSU-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- PZQBWGFCGIRLBB-NJYHNNHUSA-N [(2r)-2-[(2s,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-octadecanoyloxyethyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCCCCCCCCCCCC)[C@H]1OC[C@H](O)[C@H]1O PZQBWGFCGIRLBB-NJYHNNHUSA-N 0.000 description 2
- 238000005054 agglomeration Methods 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 2
- 229940121375 antifungal agent Drugs 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- 229940009714 erythritol Drugs 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 125000005313 fatty acid group Chemical group 0.000 description 2
- 239000010419 fine particle Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N linoleic acid group Chemical group C(CCCCCCC\C=C/C\C=C/CCCCC)(=O)O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 2
- 125000005481 linolenic acid group Chemical group 0.000 description 2
- 239000010445 mica Substances 0.000 description 2
- 229910052618 mica group Inorganic materials 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 2
- MMXZSJMASHPLLR-UHFFFAOYSA-N pyrroloquinoline quinone Chemical compound C12=C(C(O)=O)C=C(C(O)=O)N=C2C(=O)C(=O)C2=C1NC(C(=O)O)=C2 MMXZSJMASHPLLR-UHFFFAOYSA-N 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 241000894007 species Species 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- DOMXUEMWDBAQBQ-WEVVVXLNSA-N terbinafine Chemical compound C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 DOMXUEMWDBAQBQ-WEVVVXLNSA-N 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical group CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- WGVKWNUPNGFDFJ-DQCZWYHMSA-N β-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C WGVKWNUPNGFDFJ-DQCZWYHMSA-N 0.000 description 2
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- PROQIPRRNZUXQM-UHFFFAOYSA-N (16alpha,17betaOH)-Estra-1,3,5(10)-triene-3,16,17-triol Natural products OC1=CC=C2C3CCC(C)(C(C(O)C4)O)C4C3CCC2=C1 PROQIPRRNZUXQM-UHFFFAOYSA-N 0.000 description 1
- MQHLMHIZUIDKOO-OKZBNKHCSA-N (2R,6S)-2,6-dimethyl-4-[(2S)-2-methyl-3-[4-(2-methylbutan-2-yl)phenyl]propyl]morpholine Chemical compound C1=CC(C(C)(C)CC)=CC=C1C[C@H](C)CN1C[C@@H](C)O[C@@H](C)C1 MQHLMHIZUIDKOO-OKZBNKHCSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- PAFJZWHXMSQJKV-UQZRNVAESA-N (3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol;octadecanoic acid Chemical compound OC[C@@H](O)C1OC[C@H](O)[C@H]1O.OC[C@@H](O)C1OC[C@H](O)[C@H]1O.OC[C@@H](O)C1OC[C@H](O)[C@H]1O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O PAFJZWHXMSQJKV-UQZRNVAESA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- PSBDWGZCVUAZQS-UHFFFAOYSA-N (dimethylsulfonio)acetate Chemical compound C[S+](C)CC([O-])=O PSBDWGZCVUAZQS-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- 229940031723 1,2-octanediol Drugs 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- OCAPBUJLXMYKEJ-UHFFFAOYSA-N 1-[biphenyl-4-yl(phenyl)methyl]imidazole Chemical compound C1=NC=CN1C(C=1C=CC(=CC=1)C=1C=CC=CC=1)C1=CC=CC=C1 OCAPBUJLXMYKEJ-UHFFFAOYSA-N 0.000 description 1
- JPPRXACMNPYJNK-UHFFFAOYSA-N 1-docosoxydocosane Chemical compound CCCCCCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCCCCCC JPPRXACMNPYJNK-UHFFFAOYSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- RKJGFHYCZPZJPE-UHFFFAOYSA-N 2,2-bis(16-methylheptadecanoyloxymethyl)butyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C RKJGFHYCZPZJPE-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- NCLNAHJFXIKYBY-UHFFFAOYSA-N 2-hexyldecyl 16-methylheptadecanoate Chemical compound CCCCCCCCC(CCCCCC)COC(=O)CCCCCCCCCCCCCCC(C)C NCLNAHJFXIKYBY-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 description 1
- 235000006008 Brassica napus var napus Nutrition 0.000 description 1
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 description 1
- 244000188595 Brassica sinapistrum Species 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 240000002989 Euphorbia neriifolia Species 0.000 description 1
- 241000446313 Lamella Species 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- RVSTWRHIGKXTLG-UHFFFAOYSA-N Pangamic acid Natural products CC(C)N(C(C)C)C(N(C(C)C)C(C)C)C(=O)OCC(O)C(O)C(O)C(O)C(O)=O RVSTWRHIGKXTLG-UHFFFAOYSA-N 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 description 1
- 229920002359 Tetronic® Polymers 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- NCHJGQKLPRTMAO-XWVZOOPGSA-N [(2R)-2-[(2R,3R,4S)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NCHJGQKLPRTMAO-XWVZOOPGSA-N 0.000 description 1
- UDRYFKCHZFVZGJ-UHFFFAOYSA-N [5-hexadecanoyloxy-4-(hexadecanoyloxymethyl)-6-methylpyridin-3-yl]methyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC1=CN=C(C)C(OC(=O)CCCCCCCCCCCCCCC)=C1COC(=O)CCCCCCCCCCCCCCC UDRYFKCHZFVZGJ-UHFFFAOYSA-N 0.000 description 1
- RJDOZRNNYVAULJ-UHFFFAOYSA-L [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] Chemical compound [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] RJDOZRNNYVAULJ-UHFFFAOYSA-L 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 229960003204 amorolfine Drugs 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 239000010426 asphalt Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 229940066595 beta tocopherol Drugs 0.000 description 1
- 229960002206 bifonazole Drugs 0.000 description 1
- 229940073609 bismuth oxychloride Drugs 0.000 description 1
- DBZJJPROPLPMSN-UHFFFAOYSA-N bromoeosin Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C(O)C(Br)=C1OC1=C(Br)C(O)=C(Br)C=C21 DBZJJPROPLPMSN-UHFFFAOYSA-N 0.000 description 1
- MXJWRABVEGLYDG-UHFFFAOYSA-N bufexamac Chemical compound CCCCOC1=CC=C(CC(=O)NO)C=C1 MXJWRABVEGLYDG-UHFFFAOYSA-N 0.000 description 1
- 229960000962 bufexamac Drugs 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 229960002962 butenafine Drugs 0.000 description 1
- ABJKWBDEJIDSJZ-UHFFFAOYSA-N butenafine Chemical compound C=1C=CC2=CC=CC=C2C=1CN(C)CC1=CC=C(C(C)(C)C)C=C1 ABJKWBDEJIDSJZ-UHFFFAOYSA-N 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical group 0.000 description 1
- 150000001734 carboxylic acid salts Chemical class 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 239000002734 clay mineral Substances 0.000 description 1
- 229910000428 cobalt oxide Inorganic materials 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- IVMYJDGYRUAWML-UHFFFAOYSA-N cobalt(ii) oxide Chemical compound [Co]=O IVMYJDGYRUAWML-UHFFFAOYSA-N 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- VJHINFRRDQUWOJ-UHFFFAOYSA-N dioctyl sebacate Chemical compound CCCCC(CC)COC(=O)CCCCCCCCC(=O)OCC(CC)CCCC VJHINFRRDQUWOJ-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- VPWFPZBFBFHIIL-UHFFFAOYSA-L disodium 4-[(4-methyl-2-sulfophenyl)diazenyl]-3-oxidonaphthalene-2-carboxylate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC(C)=CC=C1N=NC1=C(O)C(C([O-])=O)=CC2=CC=CC=C12 VPWFPZBFBFHIIL-UHFFFAOYSA-L 0.000 description 1
- FHRUGNCCGSEPPE-UHFFFAOYSA-L disodium;2-(4,5-dibromo-3,6-dioxido-9h-xanthen-9-yl)benzoate;hydron Chemical compound [H+].[Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1C2=CC=C([O-])C(Br)=C2OC2=C(Br)C([O-])=CC=C21 FHRUGNCCGSEPPE-UHFFFAOYSA-L 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- SYELZBGXAIXKHU-UHFFFAOYSA-N dodecyldimethylamine N-oxide Chemical compound CCCCCCCCCCCC[N+](C)(C)[O-] SYELZBGXAIXKHU-UHFFFAOYSA-N 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- PROQIPRRNZUXQM-ZXXIGWHRSA-N estriol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H]([C@H](O)C4)O)[C@@H]4[C@@H]3CCC2=C1 PROQIPRRNZUXQM-ZXXIGWHRSA-N 0.000 description 1
- 229960001348 estriol Drugs 0.000 description 1
- TUKWPCXMNZAXLO-UHFFFAOYSA-N ethyl 2-nonylsulfanyl-4-oxo-1h-pyrimidine-6-carboxylate Chemical compound CCCCCCCCCSC1=NC(=O)C=C(C(=O)OCC)N1 TUKWPCXMNZAXLO-UHFFFAOYSA-N 0.000 description 1
- RFHAOTPXVQNOHP-UHFFFAOYSA-N fluconazole Chemical compound C1=NC=NN1CC(C=1C(=CC(F)=CC=1)F)(O)CN1C=NC=N1 RFHAOTPXVQNOHP-UHFFFAOYSA-N 0.000 description 1
- 229960004884 fluconazole Drugs 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 235000010382 gamma-tocopherol Nutrition 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- OIKBVOIOVNEVJR-UHFFFAOYSA-N hexadecyl 6-methylheptanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCC(C)C OIKBVOIOVNEVJR-UHFFFAOYSA-N 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- TXGJTWACJNYNOJ-UHFFFAOYSA-N hexane-2,4-diol Chemical compound CCC(O)CC(C)O TXGJTWACJNYNOJ-UHFFFAOYSA-N 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229960000448 lactic acid Drugs 0.000 description 1
- 229940033355 lauric acid Drugs 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- SLCVBVWXLSEKPL-UHFFFAOYSA-N neopentyl glycol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 description 1
- GSGDTSDELPUTKU-UHFFFAOYSA-N nonoxybenzene Chemical compound CCCCCCCCCOC1=CC=CC=C1 GSGDTSDELPUTKU-UHFFFAOYSA-N 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000012860 organic pigment Substances 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- BWOROQSFKKODDR-UHFFFAOYSA-N oxobismuth;hydrochloride Chemical compound Cl.[Bi]=O BWOROQSFKKODDR-UHFFFAOYSA-N 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 229940098695 palmitic acid Drugs 0.000 description 1
- ZQTHOIGMSJMBLM-BUJSFMDZSA-N pangamic acid Chemical compound CN(C)CC(=O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O ZQTHOIGMSJMBLM-BUJSFMDZSA-N 0.000 description 1
- 108700024047 pangamic acid Proteins 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229940100460 peg-100 stearate Drugs 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- ONQDVAFWWYYXHM-UHFFFAOYSA-M potassium lauryl sulfate Chemical compound [K+].CCCCCCCCCCCCOS([O-])(=O)=O ONQDVAFWWYYXHM-UHFFFAOYSA-M 0.000 description 1
- 229940116985 potassium lauryl sulfate Drugs 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- BTURAGWYSMTVOW-UHFFFAOYSA-M sodium dodecanoate Chemical compound [Na+].CCCCCCCCCCCC([O-])=O BTURAGWYSMTVOW-UHFFFAOYSA-M 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940082004 sodium laurate Drugs 0.000 description 1
- 229940045870 sodium palmitate Drugs 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- GGXKEBACDBNFAF-UHFFFAOYSA-M sodium;hexadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCC([O-])=O GGXKEBACDBNFAF-UHFFFAOYSA-M 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 229950004959 sorbitan oleate Drugs 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 229940117986 sulfobetaine Drugs 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 229960002722 terbinafine Drugs 0.000 description 1
- 229960000699 terbinafine hydrochloride Drugs 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- PDSVZUAJOIQXRK-UHFFFAOYSA-N trimethyl(octadecyl)azanium Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)C PDSVZUAJOIQXRK-UHFFFAOYSA-N 0.000 description 1
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 235000007680 β-tocopherol Nutrition 0.000 description 1
- 239000011590 β-tocopherol Substances 0.000 description 1
- 239000002478 γ-tocopherol Substances 0.000 description 1
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
本発明は、皮膚外用剤に関し、更に詳しくは、水中油乳化剤形の皮膚外用剤に関する。ここで、水中油乳化剤形とは、空気に面した外側の連続相が水相である乳化剤形の総称を意味し、水中油中水などの複合乳化剤形も、外側の連続相が水相である限り包含する。 The present invention relates to an external preparation for skin, and more particularly to an external preparation for skin in the form of an oil-in-water emulsifier. Here, the oil-in-water emulsifier form is a general term for an emulsifier form in which the outer continuous phase facing the air is an aqueous phase, and a composite emulsifier form such as water-in-oil-in-water is also an aqueous continuous phase. Includes as much as possible.
乳化は比重が異なり、互いに混じり合わない2種の相の一方を微細な液滴に加工して、もう一方の相の中に準安定的に分散せしめて得られる系であり、通常は前記二相は、水相と油相とからなる。水中油乳化剤形は、水性の連続相に油性の微細粒子を分散させた乳化剤形であり、外相の性質を反映し、サッパリとした使用感を有し、且つ、ヒアルロン酸などの保湿成分を有効に投与できる剤形であり、この様な乳化に於いては、前記二相の間に比重差が存するために、分散した微細粒子が会合し、二相に分離しないように、界面に界面活性剤による構造を形成させ、粒子の分散の安定化を図る必要が存し、かかる界面活性剤による構造としては、脂肪酸石鹸による界面活性剤ゲル構造や、カルボキシビニルポリマーの塩によるファンデルワールスによる水溶性高分子架橋ゲル構造が利用されている(例えば、特許文献1を参照)。しかしながら、カルボン酸の塩を利用している点で、この様な構造を保つためには系が、弱塩基性乃至は塩基性である必要が存すること、或いは、粉体などのように等電点を有する成分を多量に含む場合には、前記カルボン酸部分の電離により、粉体凝集などを誘起し、系が不安定化する場合が存するなどの課題が存したし、系の限界も存した。 Emulsification is a system obtained by processing one of two kinds of phases having different specific gravities into fine droplets and dispersing them metastable in the other phase. The phase consists of an aqueous phase and an oil phase. The oil-in-water emulsifier form is an emulsifier form in which oily fine particles are dispersed in an aqueous continuous phase, reflects the properties of the external phase, has a refreshing feeling of use, and is effective for moisturizing ingredients such as hyaluronic acid. In such emulsification, there is a difference in specific gravity between the two phases, so that the dispersed fine particles associate and do not separate into two phases. It is necessary to stabilize the dispersion of the particles by forming a structure with an agent. Examples of the structure with such a surfactant include a surfactant gel structure with a fatty acid soap and a water solution by van der Waals with a salt of a carboxyvinyl polymer. An electroconductive polymer cross-linked gel structure is used (see, for example, Patent Document 1). However, the use of a carboxylic acid salt requires that the system be weakly basic or basic in order to maintain such a structure, or isoelectricity such as powder. In the case of containing a large amount of components having points, there is a problem that the system may become unstable by inducing powder aggregation due to ionization of the carboxylic acid moiety, and there are limitations of the system. did.
この為、ゲル構造を弱体化させる成分を含有させ、水中油乳化剤形の使用感を踏襲出来る剤形を求めて研究を重ねた結果、有機変性粘土鉱物を利用した高内相油中水乳化剤形に関する技術が開発された(例えば、特許文献2を参照)が、使用感に於いて油中水乳化剤形としてはかなりサッパリとしたものが得られるようになったが、水性保湿剤の有効性を引き出す点で課題が残っていたし、使用後の脂っぽさについては、この剤形では如何ともし難いものが存した。この意味で、pH許容性が高く、且つ、粉体凝集などを起こさない、水中油乳化剤形の開発が望まれていたと言える。 For this reason, as a result of repeated research to find a dosage form that contains a component that weakens the gel structure and can follow the feeling of use of the oil-in-water emulsifier form, a high internal phase water-in-oil emulsifier form using organically modified clay minerals. Technology has been developed (see, for example, Patent Document 2), but the water-in-oil emulsifier type has become quite refreshing in terms of usability. There was still a problem in terms of drawing out, and there was something difficult in this dosage form for greasy after use. In this sense, it can be said that development of an oil-in-water emulsifier type that has high pH tolerance and does not cause powder aggregation is desired.
一方、重合度100〜200のポリオキシエチレンの脂肪酸エステルを用いた乳化系としては、ホスファチジルコリンとともにラメラ構造を作り、これを利用して、アルキル変性されていても良い、アクリル酸及び/又はメタクリル酸のポリマーの塩、並びに、脂肪酸石鹸を実質的に含有しない水中油乳化剤形を具現化する技術が開示されている(例えば、特許文献3を参照)が、ホスファチジルコリンに由来する、他の成分との相溶性、ラメラ構造を利用することによる、系の絶対的な安定性に課題を残している。この為、この様な系には粉体を含有させることが出来ず、前記課題の一つは解決していないと言える。 On the other hand, as an emulsification system using a polyoxyethylene fatty acid ester having a polymerization degree of 100 to 200, a lamella structure is formed together with phosphatidylcholine, and this may be used to modify alkyl, acrylic acid and / or methacrylic acid. A technique for embodying an oil-in-water emulsifier form substantially free of fatty acid soap and a salt of a polymer of the above is disclosed (see, for example, Patent Document 3), but with other components derived from phosphatidylcholine. Problems remain in the absolute stability of the system by using compatibility and lamellar structure. For this reason, such a system cannot contain powder, and it can be said that one of the above problems has not been solved.
他方、アルキル変性されていても良い、アクリル酸及び/又はメタクリル酸のポリマーの塩、並びに、脂肪酸石鹸を実質的に含有しない水中油乳化剤形の化粧料であって、親水性の界面活性剤として、重合度100〜200のポリオキシエチレンの脂肪酸エステルと、重合度20〜60のポリオキシエチレンの脂肪酸のエステルとを含有する皮膚外用剤は全く知られていないし、この様な系に於いて、pH許容性が高く、粉体凝集性も少ないことも全く知られていない。 On the other hand, it may be an alkyl-modified salt of acrylic acid and / or methacrylic acid polymer, and a cosmetic in the form of an oil-in-water emulsifier substantially free of fatty acid soap, as a hydrophilic surfactant No skin external preparation containing a polyoxyethylene fatty acid ester having a polymerization degree of 100 to 200 and a polyoxyethylene fatty acid ester having a polymerization degree of 20 to 60 is known at all. In such a system, It is not known at all that the pH tolerance is high and the powder cohesion is low.
本発明は、この様な状況下為されたものであり、pH許容性が高く、粉体凝集性も少ない水中油乳化剤形の皮膚外用剤を提供することを課題とする。 The present invention has been made under such circumstances, and an object of the present invention is to provide an oil-in-water emulsifier type skin external preparation having high pH tolerance and low powder cohesion.
この様な状況に鑑みて、pH許容性が高く、粉体凝集性も少ない水中油乳化剤形の皮膚外用剤を求めて、鋭意研究努力を重ねた結果、親水性の界面活性剤として、重合度100〜200のポリオキシエチレンの脂肪酸エステルと、重合度20〜60のポリオキシエチレンの脂肪酸のエステルとを含有する水中油乳化剤形がその様な特性を備えていることを見出し、発明を完成させるに至った。即ち、本発明は、以下に示すとおりである。
<1>アルキル変性されていても良い、アクリル酸及び/又はメタクリル酸のポリマーの塩、並びに、脂肪酸石鹸を実質的に含有しない水中油乳化剤形の化粧料であって、親水性の界面活性剤として、重合度100〜200のポリオキシエチレンの脂肪酸エステルと、重合度20〜60のポリオキシエチレンの脂肪酸のエステルとを含有することを特徴とする、皮膚外用剤。
<2>親油性の界面活性剤として、ステアリン酸モノグリセライドと、少なくともどちらか1方が1気圧25℃の条件下で液状である、2種以上のソルビタン脂肪酸エステルとを含有することを特徴とする、<1>に記載の皮膚外用剤。
<3>更に、セチルアルコール、ステアリルアルコール、ベヘニルアルコール及びバチルアルコールから選択される1種乃至は2種以上と、分岐の脂肪酸とを含有することを特徴とする、<1>又は<2>に記載の皮膚外用剤。
<4>その皮膚外用剤を皮膚に塗布して得られる皮膜上に、メークアップ化粧料を塗布すべき皮膚外用剤であることを特徴とする、<1>〜<3>何れか1項に記載の皮膚外用剤。
<5>化粧料であることを特徴とする、<1>〜<4>何れか1項に記載の皮膚外用剤。
In view of such circumstances, as a result of intensive research efforts to find an oil-in-water emulsifier type skin external preparation with high pH tolerance and low powder agglomeration properties, as a hydrophilic surfactant, It is found that an oil-in-water emulsifier form containing a polyoxyethylene fatty acid ester of 100 to 200 and a polyoxyethylene fatty acid ester having a polymerization degree of 20 to 60 has such characteristics and completes the invention. It came to. That is, the present invention is as follows.
<1> A salt of a polymer of acrylic acid and / or methacrylic acid, which may be alkyl-modified, and an oil-in-water emulsifier type cosmetic substantially free of fatty acid soap, which is a hydrophilic surfactant And a polyoxyethylene fatty acid ester having a polymerization degree of 100 to 200 and a polyoxyethylene fatty acid ester having a polymerization degree of 20 to 60.
<2> A lipophilic surfactant containing stearic acid monoglyceride and at least one of two or more sorbitan fatty acid esters which are liquid under conditions of 1 atm and 25 ° C. <1> The external skin preparation described in <1>.
<3> Furthermore, 1 type or 2 types or more selected from cetyl alcohol, stearyl alcohol, behenyl alcohol, and batyl alcohol, and a branched fatty acid, <1> or <2> Topical skin preparation.
<4> Any one of <1> to <3>, characterized in that it is a skin external preparation to which a makeup cosmetic should be applied on a film obtained by applying the skin external preparation to the skin. The skin external preparation as described.
<5> The skin external preparation according to any one of <1> to <4>, which is a cosmetic.
本発明によれば、pH許容性が高く、粉体凝集性も少ない水中油乳化剤形の皮膚外用剤を提供することができる。 ADVANTAGE OF THE INVENTION According to this invention, the skin external preparation of the oil-in-water emulsifier form with high pH tolerance and little powder agglomeration property can be provided.
(1)本発明の皮膚外用剤の必須成分である重合度100〜200のポリオキシエチレンの脂肪酸エステル
本発明の皮膚外用剤は、アルキル変性されていても良い、アクリル酸及び/又はメタクリル酸のポリマーの塩、並びに、脂肪酸石鹸を実質的に含有しない水中油乳化剤形の化粧料であって、親水性の界面活性剤として、重合度100〜200のポリオキシエチレンの脂肪酸エステルを必須成分として含有することを特徴とする。かかる界面活性剤において、エステルとしてモノ脂肪酸エステルも利用できるし、ジ脂肪酸エステルも利用できるが、乳化特性からはモノ脂肪酸エステルを用いることが好ましい。又、脂肪酸残基としては、ラウリン酸残基、ミリスチン酸残基、パルミチン酸残基、ステアリン酸残基、ベヘン酸残基、イソパルミチン酸残基、イソステアリン酸残基、オレイン酸残基、リノール酸残基、リノレイン酸残基等が好ましく例示でき、具体的には、モノステアリン酸ポリエチレングリコールが好ましく用いられる。ポリエチレングリコールの平均重合度としては、100〜200のものが、より好ましくは、140〜160のものが安定性の高く、ゲル構造もしっかりした水中油乳化系を形成するので好ましい。この様な平均重合度100〜200のポリオキシエチレンの脂肪酸エステルには既に市販のものが存し、かかる市販品を購入して利用することが出来る。この様な市販品としては、例えば、「AEC PEG−100 Stearate」(平均重合度100のモノステアリン酸エステル;A&E Connock社製)、「Botanimulse 100−S」(平均重合度100のモノステアリン酸エステル;Botanigenics社製)、「Crodet S100」(平均重合度100のモノステアリン酸エステル;Crodet Chemicals Europe社製)、「エマレックス6300MST」(平均重合度150のモノステアリン酸エステル;日本エマルジョン株式会社製)などが好ましく例示できる。かかる成分は、唯一種を含有させることも出来るし、二種以上を組み合わせて含有させることも出来、後記の重合度20〜60のポリオキシエチレンの脂肪酸のエステルとともに働いて、pH許容性が高く、粉体凝集性も少ない水中油乳化剤形を実現する。この為には、かかる成分は、皮膚外用剤全量に対して、総量で0.1〜2質量%含有することが好ましく、より好ましくは0.2〜1質量%である。
(1) Fatty acid ester of polyoxyethylene having a polymerization degree of 100 to 200, which is an essential component of the external preparation for skin of the present invention, is a skin external preparation of the present invention, which may be an alkyl-modified acrylic acid and / or methacrylic acid. A polymer salt and an oil-in-water emulsifier type cosmetic substantially free of fatty acid soap, containing a fatty acid ester of polyoxyethylene having a polymerization degree of 100 to 200 as an essential component as a hydrophilic surfactant It is characterized by doing. In such surfactants, mono-fatty acid esters can be used as esters, and di-fatty acid esters can be used, but it is preferable to use mono-fatty acid esters from the viewpoint of emulsification characteristics. The fatty acid residues include lauric acid residues, myristic acid residues, palmitic acid residues, stearic acid residues, behenic acid residues, isopalmitic acid residues, isostearic acid residues, oleic acid residues, linoleic acid residues. Acid residues, linolenic acid residues and the like can be preferably exemplified, and specifically, polyethylene glycol monostearate is preferably used. The average degree of polymerization of polyethylene glycol is preferably from 100 to 200, more preferably from 140 to 160, since it forms an oil-in-water emulsion system with high stability and a firm gel structure. Such fatty acid esters of polyoxyethylene having an average degree of polymerization of 100 to 200 already exist in the market, and such commercial products can be purchased and used. Examples of such commercially available products include “AEC PEG-100 Stearate” (monostearic acid ester having an average polymerization degree of 100; manufactured by A & E Connock), “Botanimulse 100-S” (monostearic acid ester having an average polymerization degree of 100 Bodogenics), “Crodet S100” (monostearic acid ester having an average degree of polymerization of 100; Crodet Chemicals Europe), “Emarex 6300MST” (monostearic acid ester having an average degree of polymerization of 150; manufactured by Nippon Emulsion Co., Ltd.) Etc. can be preferably exemplified. Such a component can contain only one species, or can contain two or more species in combination, and works together with a polyoxyethylene fatty acid ester having a polymerization degree of 20 to 60 described later, and has high pH tolerance. Realizes oil-in-water emulsifier form with less powder cohesion. For this purpose, the component is preferably contained in a total amount of 0.1 to 2% by mass, more preferably 0.2 to 1% by mass, based on the total amount of the external preparation for skin.
(2)本発明の皮膚外用剤の必須成分である重合度20〜60のポリオキシエチレンの脂肪酸のエステル
本発明の皮膚外用剤は、アルキル変性されていても良い、アクリル酸及び/又はメタクリル酸のポリマーの塩、並びに、脂肪酸石鹸を実質的に含有しない水中油乳化剤形の化粧料であって、親水性の界面活性剤として、重合度20〜60のポリオキシエチレンの脂肪酸のエステルを必須成分として含有することを特徴とする。かかる界面活性剤において、エステルとしてモノ脂肪酸エステルも利用できるし、ジ脂肪酸エステルも利用できるが、乳化特性からはモノ脂肪酸エステルを用いることが好ましい。又、脂肪酸残基としては、ラウリン酸残基、ミリスチン酸残基、パルミチン酸残基、ステアリン酸残基、ベヘン酸残基、イソパルミチン酸残基、イソステアリン酸残基、オレイン酸残基、リノール酸残基、リノレイン酸残基等が好ましく例示でき、具体的には、モノステアリン酸ポリエチレングリコールが好ましく用いられる。かかるモノステアリン酸ポリエチレングリコールに於いて、好ましいポリエチレングリコールの平均重合度は、20〜60であり、より好ましくは25〜50である。かかる成分は、前記重合度100〜200のポリオキシエチレンの脂肪酸エステルとともに働いて、pH許容性が高く、粉体凝集性も少ない水中油乳化剤形を実現する。この為には、かかる成分は、皮膚外用剤全量に対して、総量で0.5〜3質量%含有することが好ましく、より好ましくは1〜2質量%である。又、かかる含有量は、前記重合度100〜200のポリオキシエチレンの脂肪酸エステルの含有量の総量に対して、3〜6質量倍であることが好ましい。
(2) Fatty acid ester of polyoxyethylene having a polymerization degree of 20 to 60, which is an essential component of the external preparation for skin of the present invention, the external skin preparation of the present invention may be alkyl-modified acrylic acid and / or methacrylic acid And an oil-in-water emulsifier-type cosmetic substantially free of fatty acid soap, and an essential component comprising a fatty acid ester of polyoxyethylene having a polymerization degree of 20 to 60 as a hydrophilic surfactant It is characterized by containing as. In such surfactants, mono-fatty acid esters can be used as esters, and di-fatty acid esters can be used, but it is preferable to use mono-fatty acid esters from the viewpoint of emulsification characteristics. The fatty acid residues include lauric acid residues, myristic acid residues, palmitic acid residues, stearic acid residues, behenic acid residues, isopalmitic acid residues, isostearic acid residues, oleic acid residues, linoleic acid residues. Acid residues, linolenic acid residues and the like can be preferably exemplified, and specifically, polyethylene glycol monostearate is preferably used. In the polyethylene glycol monostearate, the preferable average polymerization degree of polyethylene glycol is 20 to 60, and more preferably 25 to 50. Such components work together with the polyoxyethylene fatty acid ester having a polymerization degree of 100 to 200 to realize an oil-in-water emulsifier form having high pH tolerance and low powder cohesion. For this purpose, such components are preferably contained in a total amount of 0.5 to 3% by mass, more preferably 1 to 2% by mass, based on the total amount of the external preparation for skin. Moreover, it is preferable that this content is 3-6 mass times with respect to the total content of the polyoxyethylene fatty acid ester of the said polymerization degree 100-200.
(3)本発明の皮膚外用剤
本発明の皮膚外用剤は、前記必須成分を含有し、アルキル変性されていても良い、アクリル酸及び/又はメタクリル酸のポリマーの塩、並びに、脂肪酸石鹸を実質的に含有しない水中油乳化剤形の化粧料であることを特徴とする。言い換えれば、本発明の皮膚外用剤は脂肪酸石鹸ゲルや、水溶性増粘剤の架橋ゲル構造に、その安定性を委ねていない水中油乳化剤形であり、この為、pH許容性が高く、粉体凝集性も少ない特性を有する。この様な特性をより明確なものにするためには、親油性の界面活性剤として、ステアリン酸モノグリセライドと、少なくともどちらか1方が1気圧25℃の条件下で液状である、2種以上のソルビタン脂肪酸エステルとを含有することが好ましい。前記ソルビタン脂肪酸エステルとしては、ソルビタンモノステアレート(固体)、ソルビタンセスキステアレート(固体)、ソルビタンジステアレート(固体)、ソルビタンモノラウレート(液体)、ソルビタンセスキラウレート(液体)、ソルビタンオレート(液体)、ソルビタンセスキオレート(液体)、ソルビタンモノイソステアレート(液体)、ソルビタンセスキイソステアレート(液体)等が好ましく例示できる。かかる組合せに於いて、好ましい組合せは、ソルビタンジステアレートとソルビタンセスキイソステアレートの組合せが特に好ましい。かかる組合せの質量比は、20:1〜10:1が好ましく例示できる。又、ステアリン酸モノグリセライドと、ソルビタン脂肪酸エステルの好ましい質量比は、3:1〜1:1であり、2:1〜1:1が特に好ましい。更に、親油性の非イオン界面活性剤の含有量は、総量で1〜10質量%が好ましく、2〜5質量%がより好ましい。更に詳細には、ステアリン酸モノグリセライド1〜5質量%とソルビタン脂肪酸エステルを0.5〜3質量%とを含有する形態が好適に例示できる。
(3) External preparation for skin of the present invention The external preparation for skin of the present invention contains substantially the above-mentioned essential ingredients and may be alkyl-modified, a polymer salt of acrylic acid and / or methacrylic acid, and a fatty acid soap. It is characterized by being a cosmetic in the form of an oil-in-water emulsifier that is not contained. In other words, the external preparation for skin of the present invention is an oil-in-water emulsifier type in which the stability is not entrusted to fatty acid soap gels or crosslinked gel structures of water-soluble thickeners. It also has a characteristic that the body cohesiveness is low. In order to make such characteristics clearer, as a lipophilic surfactant, at least one of stearic acid monoglyceride is liquid under the condition of 1 atm. It is preferable to contain sorbitan fatty acid ester. Examples of the sorbitan fatty acid ester include sorbitan monostearate (solid), sorbitan sesquistearate (solid), sorbitan distearate (solid), sorbitan monolaurate (liquid), sorbitan sesquilaurate (liquid), sorbitan oleate ( Liquid), sorbitan sesquioleate (liquid), sorbitan monoisostearate (liquid), sorbitan sesquiisostearate (liquid) and the like can be preferably exemplified. Among such combinations, the preferred combination is particularly preferably a combination of sorbitan distearate and sorbitan sesquiisostearate. The mass ratio of such a combination is preferably 20: 1 to 10: 1. Moreover, the preferable mass ratio of stearic acid monoglyceride and sorbitan fatty acid ester is 3: 1 to 1: 1, and 2: 1 to 1: 1 is particularly preferable. Furthermore, the total content of the lipophilic nonionic surfactant is preferably 1 to 10% by mass, and more preferably 2 to 5% by mass. More specifically, a form containing 1 to 5% by mass of stearic acid monoglyceride and 0.5 to 3% by mass of sorbitan fatty acid ester can be suitably exemplified.
本発明の皮膚外用剤においては、かかる成分以外に、通常皮膚外用剤で使用される任意成分を含有することが出来る。この様な任意成分としては、例えば、マカデミアナッツ油、アボガド油、トウモロコシ油、オリーブ油、ナタネ油、ゴマ油、ヒマシ油、サフラワー油、綿実油、ホホバ油、ヤシ油、パーム油、液状ラノリン、硬化ヤシ油、硬化油、モクロウ、硬化ヒマシ油、ミツロウ、キャンデリラロウ、カルナウバロウ、イボタロウ、ラノリン、還元ラノリン、硬質ラノリン、ホホバロウ等のオイル、ワックス類;流動パラフィン、スクワラン、プリスタン、オゾケライト、パラフィン、セレシン、ワセリン、マイクロクリスタリンワックス等の炭化水素類;オレイン酸、イソステアリン酸、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、ベヘン酸、ウンデシレン酸等の高級脂肪酸類;セチルアルコール、ステアリルアルコール、イソステアリルアルコール、ベヘニルアルコール、オクチルドデカノール、ミリスチルアルコール、セトステアリルアルコール等の高級アルコール等;イソオクタン酸セチル、ミリスチン酸イソプロピル、イソステアリン酸ヘキシルデシル、アジピン酸ジイソプロピル、セバチン酸ジ−2−エチルヘキシル、乳酸セチル、リンゴ酸ジイソステアリル、ジ−2−エチルヘキサン酸エチレングリコール、ジカプリン酸ネオペンチルグリコール、ジ−2−ヘプチルウンデカン酸グリセリン、トリ−2−エチルヘキサン酸グリセリン、トリ−2−エチルヘキサン酸トリメチロールプロパン、トリイソステアリン酸トリメチロールプロパン、テトラ−2−エチルヘキサン酸ペンタンエリトリット等の合成エステル油類;ジメチルポリシロキサン、メチルフェニルポリシロキサン、ジフェニルポリシロキサン等の鎖状ポリシロキサン;オクタメチルシクロテトラシロキサン、デカメチルシクロペンタシロキサン、ドデカメチルシクロヘキサンシロキサン等の環状ポリシロキサン;アミノ変性ポリシロキサン、ポリエーテル変性ポリシロキサン、アルキル変性ポリシロキサン、フッ素変性ポリシロキサン等の変性ポリシロキサン等のシリコーン油等の油剤類;脂肪酸セッケン(ラウリン酸ナトリウム、パルミチン酸ナトリウム等)、ラウリル硫酸カリウム、アルキル硫酸トリエタノールアミンエーテル等のアニオン界面活性剤類;塩化ステアリルトリメチルアンモニウム、塩化ベンザルコニウム、ラウリルアミンオキサイド等のカチオン界面活性剤類;イミダゾリン系両性界面活性剤(2−ココイル−2−イミダゾリニウムヒドロキサイド−1−カルボキシエチロキシ2ナトリウム塩等)、ベタイン系界面活性剤(アルキルベタイン、アミドベタイン、スルホベタイン等)、アシルメチルタウリン等の両性界面活性剤類;グリセリン脂肪酸類(モノステアリン酸グリセリン等)、プロピレングリコール脂肪酸エステル類(モノステアリン酸プロピレングリコール等)、硬化ヒマシ油誘導体、グリセリンアルキルエーテル、POEソルビタン脂肪酸エステル類(POEソルビタンモノオレエート、モノステアリン酸ポリオキエチレンソルビタン等)、POEソルビット脂肪酸エステル類(POE−ソルビットモノラウレート等)、POEグリセリン脂肪酸エステル類(POE−グリセリンモノイソステアレート等)、POEアルキルエーテル類(POE2−オクチルドデシルエーテル等)、POEアルキルフェニルエーテル類(POEノニルフェニルエーテル等)、プルロニック型類、POE・POPアルキルエーテル類(POE・POP2−デシルテトラデシルエーテル等)、テトロニック類、POEヒマシ油・硬化ヒマシ油誘導体(POEヒマシ油、POE硬化ヒマシ油等)、ショ糖脂肪酸エステル、アルキルグルコシド等の非イオン界面活性剤類;ポリエチレングリコール、グリセリン、1,3−ブチレングリコール、エリスリトール、ソルビトール、キシリトール、マルチトール、プロピレングリコール、ジプロピレングリコール、ジグリセリン、イソプレングリコール、1,2−ペンタンジオール、2,4−ヘキサンジオール、1,2−ヘキサンジオール、1,2−オクタンジオール等の多価アルコール類;ピロリドンカルボン酸ナトリウム、乳酸、乳酸ナトリウム等の保湿成分類;表面を処理されていても良い、マイカ、タルク、カオリン、合成雲母、炭酸カルシウム、炭酸マグネシウム、無水ケイ酸(シリカ)、酸化アルミニウム、硫酸バリウム等の粉体類、;表面を処理されていても良い、ベンガラ、黄酸化鉄、黒酸化鉄、酸化コバルト、群青、紺青、酸化チタン、酸化亜鉛の無機顔料類;表面を処理されていても良い、雲母チタン、魚燐箔、オキシ塩化ビスマス等のパール剤類;レーキ化されていても良い赤色202号、赤色228号、赤色226号、黄色4号、青色404号、黄色5号、赤色505号、赤色230号、赤色223号、橙色201号、赤色213号、黄色204号、黄色203号、青色1号、緑色201号、紫色201号、赤色204号等の有機色素類;ポリエチレン末、ポリメタクリル酸メチル、ナイロン粉末、オルガノポリシロキサンエラストマー等の有機粉体類;パラアミノ安息香酸系紫外線吸収剤;アントラニル酸系紫外線吸収剤;サリチル酸系紫外線吸収剤、;桂皮酸系紫外線吸収剤、;ベンゾフェノン系紫外線吸収剤;糖系紫外線吸収剤;2−(2’−ヒドロキシ−5’−t−オクチルフェニル)ベンゾトリアゾール、4−メトキシ−4’−t−ブチルジベンゾイルメタン等の紫外線吸収剤類;エタノール、イソプロパノール等の低級アルコール類;ビタミンA又はその誘導体、ビタミンB6塩酸塩、ビタミンB6トリパルミテート、ビタミンB6ジオクタノエート、ビタミンB2又はその誘導体、ビタミンB12、ビタミンB15又はその誘導体等のビタミンB類;α−トコフェロール、β−トコフェロール、γ−トコフェロール、ビタミンEアセテート等のビタミンE類、ビタミンD類、ビタミンH、パントテン酸、パンテチン、ピロロキノリンキノン等のビタミン類等;フェノキシエタノール等の抗菌剤、エストラジオール、エストリオール、ハイドロコルチゾンなどのステロイド剤、ブテナフィン、アモロルフィン、テルビナフィン、ビフォナゾール、フルコナゾールなどの抗真菌剤、インドメタシン、ブフェキサマクなどの抗炎症剤、鎮痛剤などが好ましく例示できる。 The external preparation for skin of the present invention can contain, in addition to such components, optional components that are usually used in external preparations for skin. Examples of such optional ingredients include macadamia nut oil, avocado oil, corn oil, olive oil, rapeseed oil, sesame oil, castor oil, safflower oil, cottonseed oil, jojoba oil, coconut oil, palm oil, liquid lanolin, and hardened coconut oil. Oil, wax, oil such as beeswax, canola wax, carnauba wax, ibotarou, lanolin, reduced lanolin, hard lanolin, jojoba wax, liquid paraffin, squalane, pristane, ozokerite, paraffin, ceresin, petrolatum , Hydrocarbons such as microcrystalline wax; higher fatty acids such as oleic acid, isostearic acid, lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, undecylenic acid; cetyl alcohol, stearyl alcohol, isostearyl Higher alcohols such as alcohol, behenyl alcohol, octyldodecanol, myristyl alcohol, cetostearyl alcohol; cetyl isooctanoate, isopropyl myristate, hexyldecyl isostearate, diisopropyl adipate, di-2-ethylhexyl sebacate, cetyl lactate, malic acid Diisostearyl, di-2-ethylhexanoic acid ethylene glycol, dicaprate neopentyl glycol, di-2-heptylundecanoic acid glycerin, tri-2-ethylhexanoic acid glycerin, tri-2-ethylhexanoic acid trimethylolpropane, tri Synthetic ester oils such as trimethylolpropane isostearate and pentane erythritol tetra-2-ethylhexanoate; dimethylpolysiloxane, methylphenylpoly Linear polysiloxanes such as oxane and diphenylpolysiloxane; cyclic polysiloxanes such as octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, and dodecamethylcyclohexanesiloxane; amino-modified polysiloxane, polyether-modified polysiloxane, alkyl-modified polysiloxane, Oil agents such as silicone oils such as modified polysiloxanes such as fluorine-modified polysiloxanes; Anionic surfactants such as fatty acid soap (sodium laurate, sodium palmitate, etc.), potassium lauryl sulfate, triethanolamine ether of alkyl sulfates; Cationic surfactants such as stearyltrimethylammonium, benzalkonium chloride, laurylamine oxide; imidazoline-based amphoteric surfactants (2-cocoyl-2-imida Zolinium hydroxide-1-carboxyethyloxy disodium salt, etc.), betaine surfactants (alkyl betaine, amide betaine, sulfobetaine, etc.), amphoteric surfactants such as acylmethyl taurine; glycerin fatty acids (monostearin) Glycerin acid, propylene glycol fatty acid esters (such as propylene glycol monostearate), hardened castor oil derivatives, glycerin alkyl ethers, POE sorbitan fatty acid esters (POE sorbitan monooleate, polyoxyethylene sorbitan monostearate, etc.), POE sorbite fatty acid esters (POE-sorbite monolaurate, etc.), POE glycerin fatty acid esters (POE-glycerin monoisostearate, etc.), POE alkyl ethers (POE2) Octyldodecyl ether, etc.), POE alkylphenyl ethers (POE nonylphenyl ether, etc.), Pluronic types, POE / POP alkyl ethers (POE / POP2-decyltetradecyl ether, etc.), Tetronics, POE castor oil / cured Nonionic surfactants such as castor oil derivatives (POE castor oil, POE hydrogenated castor oil, etc.), sucrose fatty acid ester, alkyl glucoside; polyethylene glycol, glycerin, 1,3-butylene glycol, erythritol, sorbitol, xylitol, multi Thor, propylene glycol, dipropylene glycol, diglycerin, isoprene glycol, 1,2-pentanediol, 2,4-hexanediol, 1,2-hexanediol, 1,2-octanediol Polyhydric alcohols; moisturizing ingredients such as sodium pyrrolidone carboxylate, lactic acid, sodium lactate; surface-treated mica, talc, kaolin, synthetic mica, calcium carbonate, magnesium carbonate, silicic anhydride (silica) ), Powders such as aluminum oxide and barium sulfate; inorganic pigments such as bengara, yellow iron oxide, black iron oxide, cobalt oxide, ultramarine, bitumen, titanium oxide, and zinc oxide, the surface of which may be treated; Pearl agents such as mica titanium, fish phosphorus foil, bismuth oxychloride, etc. whose surface may be treated; red 202, red 228, red 226, yellow 4 and blue 404 which may be raked No. 5, Yellow No. 5, Red No. 505, Red No. 230, Red No. 223, Orange No. 201, Red No. 213, Yellow No. 204, Yellow No. 203, Blue No. 1, Green No. 2 Organic pigments such as 01, purple 201, red 204, etc .; organic powders such as polyethylene powder, polymethyl methacrylate, nylon powder, organopolysiloxane elastomer; paraaminobenzoic acid ultraviolet absorbers; anthranilic acid ultraviolet rays Absorber; salicylic acid UV absorber; cinnamic acid UV absorber; benzophenone UV absorber; sugar UV absorber; 2- (2′-hydroxy-5′-t-octylphenyl) benzotriazole, 4 UV absorbers such as methoxy-4'-t-butyldibenzoylmethane; lower alcohols such as ethanol and isopropanol; vitamin A or its derivatives, vitamin B6 hydrochloride, vitamin B6 tripalmitate, vitamin B6 dioctanoate, vitamin B2 or its derivatives, vitamin B12, vitamin B15 or so Vitamin B such as derivatives; vitamin E such as α-tocopherol, β-tocopherol, γ-tocopherol, vitamin E acetate, vitamin D, vitamin H, vitamins such as pantothenic acid, panthetin, pyrroloquinoline quinone, etc .; phenoxyethanol Preferred examples include antibacterial agents such as estradiol, estriol and hydrocortisone, antifungal agents such as butenafine, amorolfine, terbinafine, bifonazole and fluconazole, anti-inflammatory agents such as indomethacin and bufexamac, and analgesics.
本発明の皮膚外用剤は、前記必須成分、任意成分を常法に従って処理することにより製造することが出来る。本発明の皮膚外用剤としては、例えば、医薬部外品を包含する化粧料、皮膚外用医薬品、皮膚外用雑貨等が好ましく例示できる。特に好ましいものは化粧料であり、これは本願発明の皮膚外用剤の使用感の心地よさに起因する。又、アルキル変性されていても良い、アクリル酸及び/又はメタクリル酸のポリマーの塩、並びに、脂肪酸石鹸を実質的に含有しないことから、これらの成分に起因する化粧崩れ伸しやすさも抑制でき、メークアップ化粧料を塗布すべき形態で使用することが好ましい。この様な形態での使用により、本発明の皮膚外用剤が形成した化粧膜上に塗布された、メークアップ化粧料の化粧持ちを著しく向上することが可能である。 The skin external preparation of this invention can be manufactured by processing the said essential component and arbitrary component in accordance with a conventional method. Preferred examples of the external preparation for skin of the present invention include cosmetics including quasi-drugs, external preparations for skin, sundries for skin use, and the like. Particularly preferred are cosmetics, which are attributed to the comfortable feeling of use of the external preparation for skin of the present invention. In addition, since it does not substantially contain a salt of a polymer of acrylic acid and / or methacrylic acid, which may be alkyl-modified, and fatty acid soap, it is possible to suppress the ease of disintegration due to these components, It is preferable to use the makeup cosmetic in a form to be applied. By using in such a form, it is possible to remarkably improve the makeup life of the makeup cosmetic applied on the cosmetic film formed by the external preparation for skin of the present invention.
以下に、実施例を挙げて本発明について、更に詳細に説明を加える。 Hereinafter, the present invention will be described in more detail with reference to examples.
下記の処方に従って、本発明の皮膚外用剤(化粧料;水中油滴乳化剤形)を作成した。即ち、イ、ロを80℃に加温し、攪拌下徐々にイにロを加え、しかる後に攪拌冷却し、本発明の皮膚外用剤1を乳液として得た。同様に操作して、「エマレックス6000MST」をPOE(45)ステアリン酸に置換した比較例1、POE(45)ステアリン酸を「エマレックス6000MST」に置換した比較例2、POE(20)ベヘニルエーテルに置換した比較例3、「エマレックス6000MST」とPOE(45)ステアリン酸をともにPOE(20)に置換した比較例3も作成した。 According to the following formulation, the external preparation for skin of the present invention (cosmetics; oil-in-water emulsifier form) was prepared. That is, a and b were heated to 80 ° C., and b was gradually added to a with stirring, followed by stirring and cooling to obtain the skin external preparation 1 of the present invention as an emulsion. In the same manner, Comparative Example 1 in which “Emalex 6000MST” was replaced with POE (45) stearic acid, Comparative Example 2 in which POE (45) stearic acid was replaced with “Emalex 6000MST”, POE (20) behenyl ether Comparative Example 3 in which “Emalex 6000MST” and POE (45) stearic acid were both substituted with POE (20) was also prepared.
<試験例1>
皮膚外用剤1、比較例1〜3及び下記に処方を示す参考例(カルボキシビニルポリマーを利用した乳液;表2)について、酸を添加した場合の40℃1ヶ月の条件での温度安定性を調べた。酸としてはクエン酸を用いた。サンプルに所定の酸を加え、1ヶ月間40℃で保存し、これを24時間かけて20℃に恒量化し、状態を観察した。結果を表3に示す。これより、本発明の皮膚外用剤はpH許容性に優れることが分かる。これは、電離性の有効成分を多量に保持できることを意味し、有効成分のベヒクルとして有用であることが分かる。
<Test Example 1>
For skin external preparation 1, Comparative Examples 1 to 3 and Reference Example (Emulsion using carboxyvinyl polymer; Table 2) shown below, the temperature stability under the condition of 40 ° C. for 1 month when acid is added Examined. Citric acid was used as the acid. A predetermined acid was added to the sample and stored at 40 ° C. for 1 month. This was constanted at 20 ° C. over 24 hours, and the state was observed. The results are shown in Table 3. This shows that the skin external preparation of this invention is excellent in pH tolerance. This means that a large amount of an ionizable active ingredient can be retained, which proves useful as a vehicle for the active ingredient.
<試験例2>
前腕内側部に2cm×4cmの部位を作成し、ここに皮膚外用剤1、比較例1〜3及び参考例の化粧料を40μl塗布し、パフで下記のファンデーション(表4)を塗布し、10分間静置した後、温水を1分間流し、水気をタオルで軽くぬぐい、地肌との色差をコニカミノルタ社製色彩色差計CR400で測定した。結果を表5に示す。これより、本発明の皮膚外用剤を塗布した上にファンデーションを塗布した場合は、ファンデーションが流水に抵抗して残存していることが分かる。これは、他のサンプルに比較して、本発明の皮膚外用剤の場合、粉体との接触により化粧料の塗布によって出来た化粧膜の構造が変化を受けにくい為であると考えられる。又、このことより、本発明の皮膚外用剤は、メークアップ化粧料をその後に施すことを前提として使用する化粧料に好適であることも分かる。
<Test Example 2>
A site of 2 cm × 4 cm is created on the inner side of the forearm, and 40 μl of the cosmetic preparation for external skin 1, Comparative Examples 1 to 3 and Reference Example is applied thereto, and the following foundation (Table 4) is applied with a puff. After standing still for 1 minute, warm water was allowed to flow for 1 minute, the moisture was lightly wiped with a towel, and the color difference with the background was measured with a color difference meter CR400 manufactured by Konica Minolta. The results are shown in Table 5. From this, it can be seen that when the foundation is applied after applying the skin external preparation of the present invention, the foundation remains in resistance to running water. This is considered to be because, in the case of the external preparation for skin of the present invention, the structure of the cosmetic film formed by applying the cosmetic by contact with the powder is less susceptible to change compared to other samples. This also shows that the external preparation for skin of the present invention is suitable for cosmetics used on the premise that makeup cosmetics are subsequently applied.
実施例1と同様に本発明の皮膚外用剤2を作成した。このものにクエン酸1質量%を添加して40℃で1ヶ月保存しても、分離は全く観察されなかった。又、試験例2の評価試験の結果はΔEが1.7であり、その効果が確認された。 The skin external preparation 2 of the present invention was prepared in the same manner as in Example 1. Even when 1% by mass of citric acid was added to this product and stored at 40 ° C. for 1 month, no separation was observed. In addition, as a result of the evaluation test of Test Example 2, ΔE was 1.7, and the effect was confirmed.
実施例1と同様に本発明の皮膚外用剤3を作成した。このものにクエン酸1質量%を添加して40℃で1ヶ月保存しても、分離は全く観察されなかった。又、試験例2の評価試験の結果はΔEが1.8であり、その効果が確認された。 The skin external preparation 3 of the present invention was prepared in the same manner as in Example 1. Even when 1% by mass of citric acid was added to this product and stored at 40 ° C. for 1 month, no separation was observed. Moreover, as a result of the evaluation test of Test Example 2, ΔE was 1.8, and the effect was confirmed.
下記に示す処方に従って、本発明の皮膚外用剤4(美白乳液化粧料)を作成した。このものは電離性の有効成分であるアルブチンを5質量%も含有しているにもかかわらず、40℃1ヶ月の保存条件で肉眼観察に於いて変化を生じなかった。 According to the prescription shown below, the skin external preparation 4 (whitening milk cosmetic) of the present invention was prepared. Although it contained as much as 5% by mass of arbutin, which is an ionizable active ingredient, it did not change under visual observation under storage conditions at 40 ° C. for one month.
下記に示す処方に従って、本発明の皮膚外用剤5(抗真菌乳液状皮膚外用医薬)を作成した。このものは電離性の有効成分であるテルビナフィン塩酸塩を5質量%も含有しているにもかかわらず、40℃1ヶ月の保存条件で肉眼観察に於いて変化を生じなかった。 According to the formulation shown below, the skin external preparation 5 of the present invention (antifungal milk external skin medicine) was prepared. Although it contained as much as 5% by mass of terbinafine hydrochloride, which is an ionizable active ingredient, it did not change under visual observation under storage conditions at 40 ° C. for one month.
本発明は、化粧料や皮膚外用医薬などの皮膚外用剤に応用できる。 The present invention can be applied to skin external preparations such as cosmetics and skin external medicines.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007328303A JP2009149554A (en) | 2007-12-20 | 2007-12-20 | Skin preparation for external use, having oil-in-water emulsion form |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007328303A JP2009149554A (en) | 2007-12-20 | 2007-12-20 | Skin preparation for external use, having oil-in-water emulsion form |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2009149554A true JP2009149554A (en) | 2009-07-09 |
Family
ID=40919150
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2007328303A Pending JP2009149554A (en) | 2007-12-20 | 2007-12-20 | Skin preparation for external use, having oil-in-water emulsion form |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2009149554A (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9655821B2 (en) | 2013-04-05 | 2017-05-23 | The Procter & Gamble Company | Personal care composition comprising a pre-emulsified formulation |
CN107296778A (en) * | 2017-08-04 | 2017-10-27 | 西南民族大学 | A kind of moisturizing face cream based on plateau cereal crops and preparation method thereof |
US9993404B2 (en) | 2015-01-15 | 2018-06-12 | The Procter & Gamble Company | Translucent hair conditioning composition |
KR20200001146A (en) * | 2018-06-27 | 2020-01-06 | 김태익 | Oil in Water Type Emulsified Cosmetic Composition Havung Low Stimulus And Preparation Method thereof |
US10806688B2 (en) | 2014-10-03 | 2020-10-20 | The Procter And Gamble Company | Method of achieving improved volume and combability using an anti-dandruff personal care composition comprising a pre-emulsified formulation |
US10912723B2 (en) | 2016-01-20 | 2021-02-09 | The Procter And Gamble Company | Hair conditioning composition comprising monoalkyl glyceryl ether |
-
2007
- 2007-12-20 JP JP2007328303A patent/JP2009149554A/en active Pending
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9655821B2 (en) | 2013-04-05 | 2017-05-23 | The Procter & Gamble Company | Personal care composition comprising a pre-emulsified formulation |
US10806688B2 (en) | 2014-10-03 | 2020-10-20 | The Procter And Gamble Company | Method of achieving improved volume and combability using an anti-dandruff personal care composition comprising a pre-emulsified formulation |
US9993404B2 (en) | 2015-01-15 | 2018-06-12 | The Procter & Gamble Company | Translucent hair conditioning composition |
US10912723B2 (en) | 2016-01-20 | 2021-02-09 | The Procter And Gamble Company | Hair conditioning composition comprising monoalkyl glyceryl ether |
CN107296778A (en) * | 2017-08-04 | 2017-10-27 | 西南民族大学 | A kind of moisturizing face cream based on plateau cereal crops and preparation method thereof |
KR20200001146A (en) * | 2018-06-27 | 2020-01-06 | 김태익 | Oil in Water Type Emulsified Cosmetic Composition Havung Low Stimulus And Preparation Method thereof |
KR102085428B1 (en) | 2018-06-27 | 2020-03-05 | 김태익 | Oil in Water Type Emulsified Cosmetic Composition Havung Low Stimulus And Preparation Method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2009149554A (en) | Skin preparation for external use, having oil-in-water emulsion form | |
WO2012017733A1 (en) | Skin cosmetic | |
JP6180816B2 (en) | Topical skin preparation | |
JP5124099B2 (en) | Oil-in-water emulsifier type cosmetic | |
JP2013053088A (en) | Powder-containing external skin care preparation | |
JP5489396B2 (en) | Skin external preparation in the form of water-in-oil emulsifier | |
JP2007308385A5 (en) | ||
JP2007308384A5 (en) | ||
JP2006298868A (en) | External preparation for skin, suitable for cleansing cosmetic | |
JP2009149555A (en) | Skin preparation for external use, having oil-in-water emulsion form | |
JP5068091B2 (en) | Emulsifier type skin external preparation | |
JP2006321725A (en) | Emulsion-form skin preparation for external use | |
JP2007045768A (en) | Neutralized and stabilized skin care preparation | |
JP2009256254A (en) | Microsphere for cosmetic and cosmetic containing the microsphere | |
JP2009149556A (en) | Skin preparation for external use, having oil-in-water emulsion form and containing powdery material | |
JP2007119419A5 (en) | ||
JP2009155241A (en) | Multilayer-treated powdery material-containing aqueous skin preparation for external use | |
JP2006104141A (en) | Gel-like cosmetic | |
JP2013129624A (en) | Skin care preparation of oil-in-water type emulsion dosage form | |
JP2013129625A (en) | Skin care preparation of water-in-oil type emulsion dosage form | |
JP2005179318A (en) | Anti-inflammatory quasi drug for skin external use | |
JP2007045766A (en) | Neutralized and stabilized skin care preparation | |
JP2007045765A (en) | Neutralized and stabilized skin care preparation | |
JP2007045764A (en) | Neutralized and stabilized skin care preparation | |
JP2005154318A (en) | Skin care preparation for external use containing carboxyvinyl polymer |